AMLX
Price
$13.49
Change
+$0.80 (+6.30%)
Updated
Oct 7 closing price
Capitalization
1.44B
29 days until earnings call
JAZZ
Price
$137.32
Change
-$0.26 (-0.19%)
Updated
Oct 7 closing price
Capitalization
8.33B
28 days until earnings call
Interact to see
Advertisement

AMLX vs JAZZ

Header iconAMLX vs JAZZ Comparison
Open Charts AMLX vs JAZZBanner chart's image
Amylyx Pharmaceuticals
Price$13.49
Change+$0.80 (+6.30%)
Volume$1.83M
Capitalization1.44B
Jazz Pharmaceuticals
Price$137.32
Change-$0.26 (-0.19%)
Volume$686.81K
Capitalization8.33B
AMLX vs JAZZ Comparison Chart in %
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. JAZZ commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and JAZZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (AMLX: $13.49 vs. JAZZ: $137.32)
Brand notoriety: AMLX and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 106% vs. JAZZ: 83%
Market capitalization -- AMLX: $1.44B vs. JAZZ: $8.33B
AMLX [@Biotechnology] is valued at $1.44B. JAZZ’s [@Biotechnology] market capitalization is $8.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while JAZZ’s TA Score has 5 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 3 bearish.
  • JAZZ’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both AMLX and JAZZ are a good buy in the short-term.

Price Growth

AMLX (@Biotechnology) experienced а -0.74% price change this week, while JAZZ (@Biotechnology) price change was +4.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was +15.97%, and the average quarterly price growth was +89.17%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

JAZZ is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($8.33B) has a higher market cap than AMLX($1.44B). JAZZ has higher P/E ratio than AMLX: JAZZ (15.38) vs AMLX (2.69). AMLX YTD gains are higher at: 256.878 vs. JAZZ (11.506). JAZZ has higher annual earnings (EBITDA): 372M vs. AMLX (-196.3M). JAZZ has more cash in the bank: 1.67B vs. AMLX (181M). AMLX has less debt than JAZZ: AMLX (5.96M) vs JAZZ (5.43B). JAZZ has higher revenues than AMLX: JAZZ (4.09B) vs AMLX (-249K).
AMLXJAZZAMLX / JAZZ
Capitalization1.44B8.33B17%
EBITDA-196.3M372M-53%
Gain YTD256.87811.5062,233%
P/E Ratio2.6915.3817%
Revenue-249K4.09B-0%
Total Cash181M1.67B11%
Total Debt5.96M5.43B0%
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXJAZZ
RSI
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
61%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 6 days ago
60%
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
57%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGFIX14.22N/A
N/A
William Blair Growth I
JAGRX64.75N/A
N/A
Janus Henderson VIT Research Instl
UBVRX82.14N/A
N/A
Undiscovered Managers Behavioral Val R2
GSAEX29.75N/A
N/A
Goldman Sachs China Equity Inv
BMSFX15.55N/A
N/A
MFS Blended Research Mid Cap Eq A

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+6.30%
XOMAO - AMLX
68%
Closely correlated
N/A
XOMAP - AMLX
51%
Loosely correlated
-0.01%
RGNX - AMLX
45%
Loosely correlated
-1.68%
OCUL - AMLX
45%
Loosely correlated
+5.01%
JAZZ - AMLX
43%
Loosely correlated
-0.19%
More